Effectiveness of GLP-1RA vs metformin for diabetes prevention in antipsychotic-treated patients

EUROPEAN NEUROPSYCHOPHARMACOLOGY · Published 2026-05-02 · DOI 10.1016/j.euroneuro.2026.112853

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.euroneuro.2026.112853

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2026

Related articles

Complexity or simplicity? A replication analysis of low heart rate as a predictor of TMS response in major depressive disorder · EUROPEAN NEUROPSYCHOPHARMACOLOGY · 2026 · Same journal
Blinding integrity in psychedelic research: Evidence from a comparative randomized controlled trial of psilocybin, MDMA, and methylphenidate in healthy volunteers · EUROPEAN NEUROPSYCHOPHARMACOLOGY · 2026 · Same journal
A call for the systematic assessment of sexual adverse events in ketamine and esketamine trials and clinical practice · EUROPEAN NEUROPSYCHOPHARMACOLOGY · 2026 · Same journal
When clinical trials fail to represent patients: implications for schizophrenia guidelines · EUROPEAN NEUROPSYCHOPHARMACOLOGY · 2026 · Same journal
Prevalence and outcomes of co-occurring psychiatric and neurological disorders: An atlas based on umbrella review of 81 meta-analyses · EUROPEAN NEUROPSYCHOPHARMACOLOGY · 2026 · Same journal
Long-term adjunctive lumateperone 42 mg treatment in major depressive disorder: Results from a 6-month open-label extension study · EUROPEAN NEUROPSYCHOPHARMACOLOGY · 2026 · Same journal
Involuntary movements integral to psychotic illness: a ‘circular epistemological journey’ informing the pathobiology and treatment of psychosis and reconceptualising tardive dyskinesia · EUROPEAN NEUROPSYCHOPHARMACOLOGY · 2026 · Same journal
Rethinking neurocognitive and cardiometabolic screening in severe mental illness · EUROPEAN NEUROPSYCHOPHARMACOLOGY · 2026 · Same journal
Dissecting the shared genetic architecture of ADHD and substance use disorders: Promising leads and persistent challenges · EUROPEAN NEUROPSYCHOPHARMACOLOGY · 2026 · Same journal
Perinatal bipolar disorder as a critical risk window: rationale for hospitalization at home on this population · EUROPEAN NEUROPSYCHOPHARMACOLOGY · 2026 · Same journal